If the assumption is true that mA1AT is the very first trigger of intracellular events causally related to HSP association and extracellular liberation16,17,44 (Fig. 6), identifying the peptides that in the complex have strong structural similarity to already known antigens in diabetes can help to prove the immunogenic potential of these new peptides. Here, HSP90B2P is linked to diabetes mellitus.